How to buy Allena Pharmaceuticals stock (ALNA)

Allena Pharmaceuticals is a biotechnology business based in the US. Allena Pharmaceuticals shares (ALNA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.01 – the same closing value as a week prior. Allena Pharmaceuticals employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Allena Pharmaceuticals stock

Buy Allena Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Allena Pharmaceuticals stock price (NASDAQ: ALNA)

Use our graph to track the performance of ALNA stocks over time.

Allena Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-06-30.

Latest market close	$0.01
52-week range	$0.00 - $0.00
50-day moving average more info button	$0.11
200-day moving average more info button	$0.27
Wall St. target price	$4.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.64

Is it a good time to buy Allena Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Allena Pharmaceuticals price performance over time

Historical closes compared with the close of $0.0112 from 2022-11-09

1 week (2024-10-03)	N/A
1 month (2024-09-10)	N/A
3 months (2024-07-10)	N/A
6 months (2024-04-10)	N/A

1 year (2023-10-10)	N/A
2 years (2022-10-14)	-20.00%
3 years (2021-10-14)	0.89
5 years (2019-10-14)	4.29

Allena Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-106.64%
Return on equity TTM	-541.02%
Profit margin	0%
Book value	$0.04
Market Capitalization more info button	$9.2 million

TTM: trailing 12 months

Allena Pharmaceuticals share dividends

We're not expecting Allena Pharmaceuticals to pay a dividend over the next 12 months.

Have Allena Pharmaceuticals's shares ever split?

Allena Pharmaceuticals's shares were split on a 1:10 basis on 4 March 2007. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Allena Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Allena Pharmaceuticals shares which in turn could have impacted Allena Pharmaceuticals's share price.

Allena Pharmaceuticals share price volatility

Over the last 12 months, Allena Pharmaceuticals's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Allena Pharmaceuticals's is 1.1491. This would suggest that Allena Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Allena Pharmaceuticals overview

Allena Pharmaceuticals, Inc. , a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts. .

Frequently asked questions

null
What percentage of Allena Pharmaceuticals is owned by insiders or institutions?
Currently 1.016% of Allena Pharmaceuticals shares are held by insiders and 7.423% by institutions. How many people work for Allena Pharmaceuticals?
Latest data suggests 12 work at Allena Pharmaceuticals. When does the fiscal year end for Allena Pharmaceuticals?
Allena Pharmaceuticals's fiscal year ends in December. Where is Allena Pharmaceuticals based?
Allena Pharmaceuticals's address is: One Newton Executive Park, Newton, MA, United States, 02462 What is Allena Pharmaceuticals's ISIN number?
Allena Pharmaceuticals's international securities identification number is: US0181191075 What is Allena Pharmaceuticals's CUSIP number?
Allena Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 018119107